Pharmacokinetic Study of Aerosolized Colimycin in Cystic Fibrosis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Pharmacokinetics of colimycin will be assessed during 12 hours after administration of 2M UI
colimycin either as an aerosol or after IV injection, the administration being separated by 5
to 10 days intervals